🗞 News

  • Alex Menys, Simon and Tom are at ECCO! Get in touch on socials or email info@motilent.io to meet for a chat and/or demo.

  • Abstracts at ECCO: Fibrosis estimation with MRI, Stricture stent, Fistula response & more

  • Motilent joins Microsoft Powershare for US data transfer (get your GIQuant without the install) 


👁 ⬇️ Look at these!

A very distended bowel

Taken from an incredibly popular post on Linkedin we see an exceptionally well prepared bowel. Full bowel prep prior to MR Enterography with a whopping 20% Mannitol.

🤔 But…. How did the patient feel? Did they make it to the bathroom? We don't know.

What's undeniable is how excellent the distention and clarity of this MRE is. At Motilent we see incredible variation in image quality and large regions of collapsed bowel. In some cases, 10y+ old sequences are being used that just need a tune. Get in touch if you would like an opinion or some examples of 'what good looks like' especially on T2, fat sat and gradient echo sequences. 


✈️🏴󠁧󠁢󠁳󠁣󠁴󠁿 Motilent at BSGAR

Motilent sits at the interface of radiology and gastroenterology (and occasionally colorectal surgery) which can make it difficult to know which meetings to go.

One thing we're certain of is none of the non-invasive technology (ie imaging) be it MRI, ultrasound or CT can be done without radiological support and that involves going all the way through to the technicians, physicists and support staff.

We are proud to be a sponsor of BSGAR 24! ⬇️

Bowel wall volume


Motilent has supported a number of projects on show at ECCO. Several of them have looked at bowel wall volume in fibrosis and treatment response measurement with some exciting results on show at ECCO. If we can get images like the ones above, quantitation becomes a whole lot easier and then, where might MRE go?

  • P067: Volumetric Assessment of Treatment Response in Newly Diagnosed Crohn's Disease: A Pilot Study (Derinkuyu et al.) 

  • P670: Intestinal Motility Changes in Patients Undergoing Removable Stent Treatment for Focal Crohn’s Disease Strictures (Das et al.) 

  • P013: MRI-Based Average T2 Signal as A Non-Invasive Measure of Fibrosis In Enteric Crohn’s Disease (Moran et al.) 

  • P276: Predictive value of changes in 3D volumetry in perianal fistulas in patients with Crohn’s disease under biologic therapy. A pilot study. (Rimola et al.)